Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
General Introduction | Xi'an Global Printing Co., Ltd. is a state-owned joint venture invested by Shaanxi Pharmaceutical Holding Group Co., Ltd Approved by the China Securities Regulatory Commission's "Zheng Jian License [2016] No. 1012" document, it was officially listed on the Shenzhen Stock Exchange on June 8, 2016. Currently, it has a company, three holding companies, and two major participating companies, covering fields such as pharmaceutical packaging, consumer goods packaging, internet marketing, industry supply chain management blockchain technology research and development. It has 108 patented products and technologies (including 4 invention patents) 50 software copyrights. Since its establishment, the company has adhered to the business philosophy of honesty and customer first. In 2021, the company was ranked 20th on the "Top 100 Chinese Printing and Packaging Enterprises" list. In recent years, the company has relied on the capital platform to improve and strengthen drug packaging, vigorously develop internet precision marketing, and cultivate industry supply chains. Its business performance has steadily improved, making due contributions to the high-quality development of Shaanxi Pharmaceutical Group. Since 2018, the company has been awarded the titles of "Shaanxi Civilized Unit" and "China Chemical Pharmaceutical Industry Association Pharmaceutical Industry Enterprise Credit Rating AAA Class Enterprise" multiple times in a row. In 2019, the company was rated as a key cultural enterprise in the "Hundred Thousand" Project of Shaanxi Province's cultural industry; In 2020, the company was awarded the title of "Outstanding Enterprise Brand for Pharmaceutical Excipients in the 2020 China Chemical and Pharmaceutical Industry", "Backbone Cultural Enterprise" awarded by the "Hundred Thousand" Cultural Industry Project in Shaanxi Province, and was awarded the "Evaluation Certificate for the Integration Management System of Industrialization and Information Technology" by the Ministry of Industry and Information Technology of the People's Republic of China. In the past two years, the company has ensured the stability of the supply chain of epidemic prevention drugs and received commendation from the China Vaccine Industry Association. |
Headquarter | Xi'an |
Establish Date | 6/28/2001 |
Listed Code | 002799.SZ |
Listed Date | 6/8/2016 |
Chairman | Lei Yongquan. |
CEO | Xia Shunwei. |
Website | www.globalprinting.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial